D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$516M |
| 2 |
Estee Lauder
EL
|
+$487M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
Nike
NKE
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$584M |
| 2 |
Tesla
TSLA
|
+$483M |
| 3 |
NVIDIA
NVDA
|
+$444M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
T-Mobile US
TMUS
|
+$296M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.67% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Healthcare | 7.82% |
| 4 | Financials | 5.66% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TALKW
3726
DELISTED
Talkspace Inc Warrant
TALKW
| $94.1K | ﹤0.01% |
817,475
+678,869
| +490% | +$61.1K |
|
3727
CALL
TG Therapeutics
TGTX
$8.58B
| $93.6K | ﹤0.01% |
11,200
| – | – |
|
3728
Garrett Motion
GTX
$5.9B
| $93.4K | ﹤0.01% |
+11,853
| New | +$91.3K |
|
3729
RUM Group Inc
RUM
$1.57B
| $93K | ﹤0.01% |
18,239
-7,103
| -28% | -$53.1K |
|
|
MRNS
3730
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $91.8K | ﹤0.01% |
11,400
-343,348
| -97% | -$2.86M |
|
3731
Polestar Automotive Holding ADS Class C-1
PSNYW
$404M
| $91.5K | ﹤0.01% |
7,682
| – | – |
|
3732
Nuvation Bio
NUVB
$2.24B
| $91.1K | ﹤0.01% |
67,971
-44,265
| -39% | -$73.7K |
|
|
BHR
3733
Braemar Hotels & Resorts
BHR
$153M
| $90.7K | ﹤0.01% |
+32,727
| New | +$102K |
|
3734
American Well
AMWL
$181M
| $89.9K | ﹤0.01% |
3,841
+916
| +31% | +$30.9K |
|
3735
UWM Holdings
UWMC
$621M
| $89.3K | ﹤0.01% |
18,419
-18,586
| -50% | -$107K |
|
|
WHWK
3736
Whitehawk Therapeutics
WHWK
$183M
| $89.3K | ﹤0.01% |
+18,450
| New | +$107K |
|
|
DMAQR
3737
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
| $89K | ﹤0.01% |
296,800
| – | – |
|
|
DZSI
3738
DELISTED
DZS Inc. Common Stock
DZSI
| $88.5K | ﹤0.01% |
+42,132
| New | +$121K |
|
|
MRSN
3739
DELISTED
Mersana Therapeutics
MRSN
| $86.1K | ﹤0.01% |
2,711
-36,719
| -93% | -$1.75M |
|
|
SLGCW
3740
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $85.9K | ﹤0.01% |
390,303
| – | – |
|
3741
Mistras Group
MG
$492M
| $85.7K | ﹤0.01% |
15,725
-42,642
| -73% | -$268K |
|
3742
Joby Aviation
JOBY
$6.82B
| $85.3K | ﹤0.01% |
+13,230
| New | +$104K |
|
3743
InnovAge Holding
INNV
$1.57B
| $83.7K | ﹤0.01% |
13,970
-2,513
| -15% | -$16.3K |
|
3744
Rocket Lab Corp
RKLB
$39.9B
| $81.6K | ﹤0.01% |
18,630
-14,300
| -43% | -$87K |
|
3745
MaxCyte
MXCT
$116M
| $78.5K | ﹤0.01% |
25,162
-23,420
| -48% | -$94.2K |
|
|
KNTE
3746
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $78.1K | ﹤0.01% |
55,810
-4,299
| -7% | -$10.3K |
|
3747
CALL
Stem
STEM
$49.2M
| $75K | ﹤0.01% |
885
+170
| +24% | +$19.4K |
|
|
CLLS
3748
Cellectis
CLLS
$286M
| $74.5K | ﹤0.01% |
47,154
-31,675
| -40% | -$61.9K |
|
3749
Goldgroup Mining Inc.
GORO
$151M
| $73.9K | ﹤0.01% |
172,604
+96,646
| +127% | +$51.7K |
|
|
CIM
3750
Chimera Investment
CIM
$1.05B
| $73K | ﹤0.01% |
4,459
-1,572
| -26% | -$27.6K |
|
Similar funds
D.E. Shaw & Co's Q3 2023 Portfolio in Review
As of Q3 2023, D.E. Shaw & Co held 4,689 positions worth $95.8B, down 2.2% from $97.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $2.99B in Q3 2023, closing 473 positions and reducing 1,535 holdings. Its most notable exit was State Street Consumer Staples Select Sector SPDR ETF, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in NiSource Inc. Series A Corporate Units worth $52.6M.
- D.E. Shaw & Co's largest Q3 2023 buy was NiSource Inc. Series A Corporate Units: 540,000 shares worth $52.6M.
- D.E. Shaw & Co added most to Amazon in Q3 2023, an estimated $516M increase.
- D.E. Shaw & Co's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $584M.
- D.E. Shaw & Co fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2023, selling an estimated $174M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $95.8B portfolio in Q3 2023.
- D.E. Shaw & Co opened 482 new positions and closed 473 in Q3 2023.
- D.E. Shaw & Co's portfolio value fell 2.2% quarter-over-quarter to $95.8B.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.